Jeff Frey

Jeff Frey has had an extensive work experience in the biotechnology and consulting industries. Jeff currently serves as the Chief Commercial Officer and a member of the Board of Directors at APEX Biologix since March 2021. Prior to this, they held the position of Chief Commercial Officer at Axolotl Biologix from January 2019 to March 2021.

Before entering the biotechnology field, Jeff worked as a Biologics Consultant at Triumph Consulting from May 2018 to January 2019. Jeff also held the role of US General Manager at Orthosolutions from February 2014 to May 2018, where they successfully led nationwide sales from $0 to $5,000,000 within three years and was responsible for PNL.

Jeff's career in sales and leadership began at Integra Life Sciences in October 2005, where they served as Vice President of Sales until March 2013. During their tenure, they played a crucial role in achieving 23 consecutive quarters of double-digit growth and was responsible for PNL. Additionally, they held the position of National Sales Manager at Integra from an unspecified date in 2005 to 2010.

Jeff also worked as the Vice President of Sales at Vision Scope from April 2013 to February 2014 and as an Area Sales Director at Integra from October 2008 to February 2009.

Overall, Jeff Frey's work experience demonstrates their expertise in biotechnology sales, leadership, and consulting roles, making him a valuable asset in driving commercial success and growth within the organizations they have worked with.

Jeff Frey earned a Bachelor of Applied Science (BASc) degree in Economics from Rutgers University. The start and end years of their education are not provided.